Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Lebanese-Canadian Hospital (LCH) was a private medical facility located in Sin el Fil, a suburb of Beirut, Lebanon. It provided a range of healthcare services including general surgery, internal medicine, diagnostic imaging, and emergency care. In February 2011, the hospital gained international notoriety when the U.S. Department of the Treasury designated it as a "primary money laundering concern" under the USA PATRIOT Act. The designation was based on allegations that the hospital was used to facilitate financial transactions for a global narcotics and money-laundering network linked to Hezbollah. Following the resulting financial sanctions and legal pressure, the hospital's assets were sold to Saint Joseph Hospital, and the original entity ceased operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lebanese-Canadian Hospital.